Health Canada Approves Auscul-X Stethoscope System for Sale In Canada

AusculSciences’ remote, disposable stethoscope system enables healthcare professionals to listen to patients’ hearts and lungs remotely.

OTTAWA, CANADA – January 22, 2021 – AusculSciences™, a pioneer in developing advanced acoustic technologies to detect cardiovascular and pulmonary conditions, today announced that Health Canada has issued a Medical Device License (MDL) for its Auscul-X™ Touchless Stethoscope System (“Auscul-X”), allowing it to be sold in Canada.  Auscul-X is a remote, disposable stethoscope which allows physicians and nurses to listen to, record and visualize amplified and filtered heart and lung sounds from outside the patient’s room (including in remote, teleauscultation applications), helping to keep healthcare professionals at a safe distance from patients with diagnosed or suspected infectious diseases, such as COVID-19.  Protecting the health and safety of frontline healthcare workers is one of the five priorities identified by the Canadian Medical Association  to prepare for a potential COVID-19 resurgence.

AusculSciences had previously been awarded a contract under the Innovative Solutions Canada program whereby the Canadian Special Operations Forces Command successfully evaluated Auscul-X.  Auscul-X is currently being evaluated on critical care patients in an investigator-led study at the University of Ottawa Heart Institute, which began in mid-2020.

“The approval of Auscul-X in Canada represents an important milestone for AusculSciences, and a critical enhancement to the protection of healthcare professionals,” said Michael Lahr, President of AusculSciences.  “We are thrilled to be able to offer this innovative solution to the market”.

Over 10% of those infected with COVID-19 are healthcare professionals and physical distancing is one of the most important means by which people can reduce their risk of contracting infectious diseases.  Auscul-X provides a means by which physical distancing can be maintained during patient examinations, thereby reducing healthcare professionals’ exposure to infectious disease, such as COVID-19.   In addition, Auscul-X’s recording capability can provide health care professionals the ability to examine the heart and lung sounds of patients who live in remote areas and do not have conventional access to healthcare.

AusculSciences expects Auscul-X to be on-market in other jurisdictions throughout 2021.

About AusculSciences

AusculSciences is a medical device, services, and software solutions company dedicated to the development of acoustic technologies to detect cardiovascular and pulmonary conditions.  AusculSciences’ innovative approach provides physicians and nurses with actionable data to support clinical decision making, reduce the cost of diagnoses while improving patient care and provider safety.

For more information, contact:

John Phillips
Vice President, Business Development
AusculSciences
Tel: +1-613-763-0088 ext. 102
Email: john@ausculsciences.com
Twitter: @ausculsciences